CONBA USA
GenericsCONBA USA is a generic drug manufacturer focused on Gastroenterology.
CONBA USA's Key Drugs
CONBA USA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
CONBA USA's Recent FDA Approvals
New NDA/BLA approvals for CONBA USA over the last two years — novel drugs only, excluding generics and label supplements.
CONBA USA's Therapeutic Areas
CONBA USA's approved drugs and pipeline span 1 therapeutic area, led by Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CONBA USA's Top Competitors
CONBA USA's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CONBA USA Pipeline Snapshot
Active clinical trials for CONBA USA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Gastroenterology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2024-12-23
- Latest
- 2025-03-14
- Applications
- 2